The Experimental Therapeutics (ET) Program is the engine for a virtuous cycle of bench-to-bedside-and-back research and clinical implementation that connects and coordinates discoveries made in the basic sciences with translational research and clinical trials.

The Program’s overarching goal is to improve patient outcomes by identifying and validating novel therapeutic targets, fostering translational research, and conducting clinical research to assess the effectiveness of new treatments in humans.

Within those themes, the ET Program has two specific aims:

1. To identify and advance new cancer therapies grounded in HCI’s basic and translational research
2. To develop innovative treatments and conduct translational and clinical research focused on cancers relevant to our catchment area